Research Article
Optical Coherence Tomography Angiography Characteristics of Polypoidal Lesions in Caucasians
Table 2
Patient information summary.
| | Patient no | Sex | Age | Laterality | Origin | No. of polypoidal lesions in ICGA | B-scan SS-OCTA | En face SS-OCTA | BNVN | Max. PED height (µm) of polypoidal lesions | SFCT (µm) | Retinal hemorrhage | No. of previous intravitreal antiVEGF injections | | Circumscribed flow | Diffuse flow | Tangled vessel balls | Vascular dilatations | Ill-definedvascular networks |
| | 1 | M | 63 | OS | PCDS | 1 | − | + | − | + | − | + | 76 | 330 | − | 0 | | 2 | M | 66 | OS | PCDS | 1 | − | + | − | + | − | + | 98 | 333 | − | 1 | | 3 | M | 74 | OD | PCDS | 1 | + | − | + | − | − | + | 176 | 346 | − | 0 | | 4 | M | 75 | OD | AMD | 2 | + | − | + | + | − | + | 593 | 292 | + | 0 | | + | − | + | + | − | | 333 | | 5 | M | 90 | OD | AMD | 1 | − | + | − | − | + | + | 313 | 195 | − | 0 | | 6 | F | 76 | OD | AMD | 1 | + | − | − | − | + | + | 142 | 84 | + | 0 | | 7 | M | 76 | OS | AMD | 1 | + | − | + | − | − | − | 267 | 164 | − | 0 | | 8 | F | 51 | OS | PCDS | 7 | + | − | + | + | − | + | 855 | 425 | + | 6 | | + | − | − | + | − | | 1088 | | + | − | + | + | − | | 953 | | + | − | − | + | − | | 633 | | + | − | + | − | − | | 571 | | + | − | − | + | − | | 887 | | + | − | + | − | − | | 390 | | 9 | F | 74 | OS | AMD | 1 | + | − | + | − | − | + | 474 | 38 | − | 0 | | 10 | F | 74 | OD | Idiopathic | 1 | − | + | − | − | + | − | 145 | 170 | − | 0 | | 11 | M | 81 | OS | AMD | 1 | − | + | + | + | − | + | 264 | 185 | + | 0 | | 12 | F | 59 | OD | PCDS | 1 | + | − | + | − | − | + | 198 | 340 | − | 28 | | 13 | M | 76 | OD | AMD | 1 | + | − | + | − | − | − | 158 | 154 | − | 13 | | 14 | M | 76 | OS | AMD | 1 | + | − | + | − | − | + | 232 | 326 | − | 0 | | 15 | F | 84 | OS | AMD | 1 | − | + | − | − | + | + | 411 | 169 | + | 0 | | 16 | F | 52 | OD | PCDS | 1 | + | − | − | − | − | + | 165 | 394 | − | 8 | | 17 | F | 70 | OS | Idiopathic | 2 | + | − | + | − | − | − | 169 | 240 | + | 0 | | + | − | + | − | − | | 148 | | 18 | M | 71 | OD | AMD | 1 | + | − | + | − | − | + | 223 | 287 | + | 1 | | 19 | F | 73 | OS | PCDS | 1 | − | + | − | − | + | + | 79 | 378 | − | 0 | | 20 | M | 83 | OD | AMD | 1 | − | + | − | − | − | − | 58 | 68 | + | 19 | | 21 | F | 83 | OD | AMD | 1 | + | − | − | + | − | − | 85 | 82 | − | 0 | | 22 | F | 85 | OS | AMD | 2 | + | − | + | + | − | + | 214 | 332 | − | 26 | | + | − | + | − | − | | 178 | | 23 | F | 64 | OS | Idiopathic | 2 | + | − | + | − | − | + | 240 | 259 | − | 0 | | + | − | + | − | − | + | 172 | 259 | − | 0 | | 24 | M | 58 | OS | PCDS | 1 | − | + | − | + | − | + | 190 | 209 | + | 0 | | 25 | F | 84 | OS | AMD | 1 | + | − | + | − | − | + | 97 | 192 | + | 0 | | 26 | F | 79 | OS | AMD | 1 | + | − | − | − | + | + | 271 | 84 | + | 0 | | 27 | M | 60 | OS | PCDS | 1 | + | − | − | + | − | + | 572 | 371 | − | 10 | | 28 | F | 71 | OS | PCDS | 2 | + | − | + | − | − | + | 282 | 374 | − | 21 | | + | − | + | − | − | | 108 | | 29 | F | 69 | OD | PCDS | 1 | + | − | + | − | − | + | 229 | 257 | − | 1 | | 30 | M | 73 | OS | PCDS | 1 | − | + | − | − | + | + | 85 | 289 | − | 14 | | 31 | M | 67 | OS | PCDS | 1 | + | − | + | − | − | + | 170 | 271 | − | 10 | | 32 | F | 71 | OD | AMD | 1 | + | − | − | − | + | + | 143 | 165 | − | 0 |
|
|
SS-OCTA = swept source optical coherence tomography angiography; ICGA = indocyanine green angiography; BNVN = branching neovascular network; PED = pigment epithelial detachment; SFCT = subfoveal choroidal thickness; anti-VEGF = antivascular endothelial growth factor; M = male; OS = oculus sinister; PCDS = pachychoroid disease spectrum; OD = oculus dexter; AMD = age-related macular degeneration; F = female; Idiopathic = origin not classified as PCDS, AMD, inflammatory, choroidal osteoma, or choroidal melanoma.
|
